PLRX icon

Pliant Therapeutics
PLRX

Overview Fund Activity

134 hedge funds and large institutions have $1.14B invested in Pliant Therapeutics in 2023 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 53 increasing their positions, 34 reducing their positions, and 20 closing their positions.

Holders
134
Holders Change
-2
Holders Change %
-1.47%
% of All Funds
1.96%
Holding in Top 10
7
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-12.5%
% of All Funds
0.1%
New
19
Increased
53
Reduced
34
Closed
20
Calls
$2.06M
Puts
$5.88M
Net Calls
-$3.81M
Net Calls Change
-$4.73M

Top Buyers

1
BOCH
1
Blue Owl Capital Holdings
New York
$54.4M
2
Morgan Stanley
2
Morgan Stanley
New York
$14.7M
3
FLAM
3
First Light Asset Management
Minnesota
$65M
4
BlackRock
4
BlackRock
New York
$87M
5
T. Rowe Price Associates
5
T. Rowe Price Associates
Maryland
$68.6M

Top Sellers

1
RCM
1
RA Capital Management
Massachusetts
$23.2M
2
First Manhattan
2
First Manhattan
New York
$0
3
WP
3
Woodline Partners
California
$2.25M
4
VA
4
VR Adviser
New York
$0
5
Fidelity Investments
5
Fidelity Investments
Massachusetts
$71.8M
Name Holding Trade Value Shares
Change 		Shares
Change %
AG
151
Artal Group
Luxembourg
– -$26K -1,490 Closed
QCG
152
Quadrant Capital Group
Ohio
– -$2.81K -162 Closed
3 4 5 6
7